| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/05/2001 | CN1311227A New polypeptide-human sec 5 protein 37 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311224A New polypeptide-human protein 40 containing olfactory structure region and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311221A New polypeptide-human arginine degradation relative protein 46 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311215A New polypeptide-human immune response factor 64 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311214A New polypeptide-human fibre protogrowth factor receptor 11 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311213A New polypeptide-human tubular agent 30 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311211A New polypeptide-human cyclotubulin 63 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311210A New polypeptide-human zinc finger protein 49 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311209A New polypeptide-human ataxia-telangiectatic mutation protein 9 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311207A New polypeptide-human zinc finger protein 51 and polynucleotide for coding sand polypeptide |
| 09/05/2001 | CN1311206A New polypeptide-human mPer 3-23 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311205A New polypeptide-human micronucleus protein 9 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311201A New polypeptide-human reverse transcription relative protein 15 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311199A New polypeptide-human actin filament protein 21 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311193A New polypeptide-DNA prosthetic protein rad-18-22 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311192A New polypeptide-KIAA 0986-35 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311191A New polypeptide-transcript modulator 47 and polynucleotide for coding such polypeptide |
| 09/05/2001 | CN1311190A New polypeptide-NSD1-27 and polynucleotide for coding such polypeptide |
| 09/05/2001 | CN1070611C Hybridoma cell lines and thier monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
| 09/04/2001 | US6284882 Myostatin gene promoter and inhibition of activation thereof |
| 09/04/2001 | US6284881 A nucleic acid molecule; diagnosis and therpy for allergies, parasitic infections, b cell neoplasia and atopic diseases |
| 09/04/2001 | US6284875 Method for recovering proteins from the interstitial fluid of plant tissues |
| 09/04/2001 | US6284873 Complex of human kallikrein 2 (hK2) and protease inhibitor-6 (PI-6) in prostate tumor tissue and methods of using the complex |
| 09/04/2001 | US6284742 Administering adenovirus and antibodies |
| 09/04/2001 | US6284740 Osteoprotegerin |
| 09/04/2001 | US6284728 Osteoprotegerin |
| 09/04/2001 | US6284540 Neuronal trophic support and cell differentiation by introducing nucleotide sequence |
| 09/04/2001 | US6284536 Modified immunoglobin molecules and methods for use thereof |
| 09/04/2001 | US6284522 Isolated and purified DNA molecule and protein for the degradation of triazine compounds |
| 09/04/2001 | US6284515 Signal recognition particle polypeptides and polynucleotides |
| 09/04/2001 | US6284507 Mitofusin genes and their uses |
| 09/04/2001 | US6284491 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 09/04/2001 | US6284489 Enzymatic polypeptide for use in screening bactericides; wound healing agents; for prevention of bacterial infections |
| 09/04/2001 | US6284488 Protein expression system |
| 09/04/2001 | US6284485 Nucleic acids encoding osteoprotegerin |
| 09/04/2001 | US6284476 Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individuals |
| 09/04/2001 | US6284474 Monitoring lung damage in humans; incubate monoclonal antibody with test sample, detect monoclonal antibody bound to preferential polypeptide, detection of preferential binding indicates lung damage |
| 09/04/2001 | US6284472 Method for extending the range of an immunoassay |
| 09/04/2001 | US6284471 Chimeric immunoglobulin; for the diagnosis and treatment of bacterial infection, cancer and septic shock |
| 09/04/2001 | US6284456 Transcriptional coactivator that interacts with Tat protein and regulates its binding to TAR RNA, methods for modulating Tat transactivation, and uses therefor |
| 09/04/2001 | US6284454 Variant of LAV viruses |
| 09/04/2001 | US6284255 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 09/04/2001 | US6284253 Aids in cats |
| 09/04/2001 | US6284239 Murine model for human carcinoma |
| 09/04/2001 | US6284236 Cytokine that induces apoptosis |
| 08/30/2001 | WO2001063299A1 METHOD FOR CORRELATING BLOOD COAGULATION ACTIVITY WITH MARKERS IN BODY FLUIDS, e.g. URINE |
| 08/30/2001 | WO2001063280A2 Inter-alpha-trypsin as a marker for sepsis |
| 08/30/2001 | WO2001062974A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 08/30/2001 | WO2001062969A2 Estrogen receptor alpha variants and methods of detection thereof |
| 08/30/2001 | WO2001062954A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 08/30/2001 | WO2001062940A2 New phosphodiesterase type 7b |
| 08/30/2001 | WO2001062934A1 Starch branching enzyme |
| 08/30/2001 | WO2001062933A2 Muteins of interleukin-13 (il-13) |
| 08/30/2001 | WO2001062932A1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 08/30/2001 | WO2001062931A2 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |
| 08/30/2001 | WO2001062930A1 Activated vitronectin as a marker of angiogenesis detected with phage antibodies |
| 08/30/2001 | WO2001062925A2 103p2d6: tissue specific protein highly expressed in various cancers |
| 08/30/2001 | WO2001062923A2 Transporters and ion channels |
| 08/30/2001 | WO2001062915A1 Novel protein and gene encoding the same |
| 08/30/2001 | WO2001062914A1 Bcmp 84, a protein associated to breast cancer |
| 08/30/2001 | WO2001062908A2 Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| 08/30/2001 | WO2001062907A1 Antibody library |
| 08/30/2001 | WO2001062895A2 Simultaneous stimulation and concentration of cells |
| 08/30/2001 | WO2001062801A2 Humanized antibodies that sequester amyloid beta peptide |
| 08/30/2001 | WO2001062800A1 Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis |
| 08/30/2001 | WO2001062793A2 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | WO2001062792A2 Cancer treatment and prognosis involving hes-1 protein |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062786A2 Tlp peptides and dna sequences coding the same |
| 08/30/2001 | WO2001062784A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | WO2001062779A2 New transcription factor carp-2 |
| 08/30/2001 | WO2001062778A2 Tumour-specific animal proteins |
| 08/30/2001 | WO2001062300A2 Caspase activated prodrugs therapy |
| 08/30/2001 | WO2001062298A2 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 08/30/2001 | WO2001062288A1 Membrane estrogen receptor-directed therapy in breast cancer |
| 08/30/2001 | WO2001062287A1 Methods of prevention and treatment of asthma, and allergic conditions |
| 08/30/2001 | WO2001062286A1 Novel antibody with specificity for colon cancer |
| 08/30/2001 | WO2001062285A1 Use of il-18 inhibitors |
| 08/30/2001 | WO2001012847A3 Isolation of cells from forensic samples for dna-typing |
| 08/30/2001 | WO2001012806A3 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 08/30/2001 | WO2001012776A3 18 human secreted proteins |
| 08/30/2001 | WO2001009187A3 Human monoclonal antibodies to her2/neu |
| 08/30/2001 | WO2001002568A3 Human genes and gene expression products |
| 08/30/2001 | WO2000073794A3 Method for separating cells using immunorosettes |
| 08/30/2001 | WO2000040733A9 Human cyclic nucleotide pdes |
| 08/30/2001 | WO2000040614A9 Characterization of the soc/crac calcium channel protein family |
| 08/30/2001 | WO2000040597A9 Method and composition for angiogenesis inhibition |
| 08/30/2001 | US20010018508 Tumour necrosis factor binding ligands |
| 08/30/2001 | US20010018507 Complexing |
| 08/30/2001 | US20010018419 Isolated and purified; Rh antigens which can be immobilized and used in hematology, for isolation and purification of anti-Rh antibodies from solutions; useful in treatment of hemolytic disease of newborn |
| 08/30/2001 | US20010018211 Mutation suppresses apoptosis, permits cell proliferation; peptides including domain and nucleotides encoding domain useful for screening tumors for proliferative mutations |
| 08/30/2001 | US20010018201 Using hapten |
| 08/30/2001 | US20010018198 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 08/30/2001 | US20010018193 Epitopes; medical diagnosis |
| 08/30/2001 | US20010018191 Immunology complex with epitopes; Alzheimer's disease |
| 08/30/2001 | US20010018189 Crohn's disease, skin disorders, antiallergens |
| 08/30/2001 | US20010018187 Coreactant-including electrochemiluminescent compounds, methods, systems and kits utilizing same |
| 08/30/2001 | US20010018053 Methods for treating disease states comprising administration of low levels of antibodies |
| 08/30/2001 | US20010018052 Use of anti-coagulation factor antibodies as long-lasting protective agents |
| 08/30/2001 | US20010018041 Lymphomas, leukemia |